Phylos Bioscience
PrivateLast Round
Debt
Dec 31, 2025
Total Funding Raised
$29.35M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Phylos Bioscience operates in Healthcare & Life Sciences and is based in Portland, Oregon. Its latest recorded funding round was a Debt round in December 2025.
Phylos Bioscience is a crop science company that develops and sells advanced cannabis and hemp genetics, including F1 hybrid seeds and natural THCV products, to empower growers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Phylos Bioscience Comparables
Compare Phylos Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Dewey Scientific | 84% | |
| Sunrise Genetics | 83% | |
| Segra International | 83% |
For institutional investors. Book with your work email.
Phylos Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Dec 31, 2025 | ||||
| Early Funding | Dec 9, 2025 | ||||
| Strategic | Dec 31, 2024 | ||||
| Early Funding | Oct 15, 2024 | ||||
| Early Funding | Nov 1, 2023 | ||||
Convertible Debt | May 25, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Phylos Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Accomplice | Series B |
| Entourage Effect Capital | Series B |
| Merida Capital Partners | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 54% MoM.
- Jul 20, 2026
Open roles increased to 49, 98% of headcount.
For institutional investors. Book with your work email.
Phylos Bioscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Phylos Bioscience's valuation, stock price, and market status.
Is Phylos Bioscience a public or private company?
Phylos Bioscience is a private company.
What is the current stock price of Phylos Bioscience?
Phylos Bioscience is a private company, so its shares have no public market price. Caplight tracks Phylos Bioscience's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Phylos Bioscience worth (valuation)?
Valuation information for Phylos Bioscience is not publicly available.
Can I buy Phylos Bioscience stock?
Phylos Bioscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Phylos Bioscience's last funding round?
Phylos Bioscience's most recent funding round was Debt on December 31, 2025.
Who are the main investors in Phylos Bioscience?
Key investors in Phylos Bioscience include Merida Capital Partners.
Will Phylos Bioscience IPO soon?
No public IPO plans have been announced for Phylos Bioscience.
How can I track Phylos Bioscience secondary market activity?
Caplight tracks bids, offers, and trades in Phylos Bioscience's shares on secondary markets.